COMMUNIQUÉS West-GlobeNewswire

DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare
05/06/2024
Châtillon, France, le 5 juin (22 :30 CEST) 2024 DBV Technologies participera à la 45e conférence annuelle Goldman Sachs Global Healthcare DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— [...]
AVITA Medical Achieves Milestone with First Case Using RECELL GO
05/06/2024
Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects VALENCIA, Calif., June 05, [...]
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
05/06/2024
WALTHAM, Mass. and DUBLIN, June 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to [...]
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
05/06/2024
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company [...]
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced [...]
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
05/06/2024
Initial triplet combination of RLY-2608 + atirmociclib + fulvestrant to be evaluated in patients with PI3Kα-mutated HR+/HER2- metastatic breast cancer; initiation planned by end of 2024 CAMBRIDGE, Mass., June 05, 2024 ( [...]
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe
05/06/2024
New QIAcuity digital PCR Custom Assay Design Tool for copy number variation analysis supports researchers’ customization needs, complementing QIAGEN’s existing pre-designed assays // GeneGlobe Design and Analysis Hub [...]
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
05/06/2024
PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
05/06/2024
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman [...]
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers
05/06/2024
VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice Additive effects were observed for VTX3232 in combination with the GLP [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/06/2024
WESTLAKE VILLAGE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
05/06/2024
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTCMKTS: CBIH), to fund the clinical data collection efforts [...]
Oxford Treatment Center Launches New Christian-Based Treatment Program for Those Struggling with Drug and Alcohol Addiction
05/06/2024
ETTA, Miss., June 05, 2024 (GLOBE NEWSWIRE) -- Oxford Treatment Center, a leading addiction treatment provider, has introduced a new Christian-based treatment program, offering patients the option to have a spiritually [...]
Dr María José Torres, responsable du département d’allergologie à l’Hôpital universitaire régional de Malaga, nouvelle présidente de l’EAACI
05/06/2024
L’EAACI met l’accent sur la santé planétaire en tant qu’élément clé de son programme de recherche VALENCE, Espagne, 05 juin 2024 (GLOBE NEWSWIRE) -- Le Congrès 2024 de l’EAACI, un forum rassemblant des experts dans les [...]
New Nymbl Science Report Asks: Are Falls an Invisible Epidemic?
05/06/2024
Digital health leader shares results from large-scale studies that prove preventive programs help mitigate fall risks DENVER, June 05, 2024 (GLOBE NEWSWIRE) -- Nymbl Science , a digital health provider and leader in [...]
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024
Media Release COPENHAGEN, Denmark; June 05, 2024 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Financial Officer Anthony Pagano and Chief Operating Officer Anthony Mancini will participate in a fireside chat [...]
Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six Months of Treatment in Late-Breaking Poster Presentation at EASL Congress 2024
05/06/2024
Results show combination of OCA 5-10 mg and bezafibrate 400 mg normalizes multiple serum biomarkers that are associated with improved transplant-free and decompensation-free survival in PBC MORRISTOWN, N.J., June 05, [...]
InflaRx Hosts R&D Event Highlighting the Promise of INF904
05/06/2024
Thought leaders in complement inhibition, chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) provide compelling new insights into the strong development rationales, potential differentiation and [...]

Pages